KRAS-variant

second breast cancer3

The KRAS-variant and Second Cancer Risk

A second cancer diagnosis is often a concern of cancer patients. Although it seems unfair to have to go through the whole cancer journey again, the good news is that it is…

Read More ➝
ForeverypersonwithaBRCAvariant

Understanding different genetic causes of cancer: BRCA variants vs. the KRAS-variant

This post explores BRCA variants vs. the KRAS-variant and is part two in our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic…

Read More ➝
Screen Shot 2022 12 16 at 1.33.23 PM

Understanding the different causes of cancer: genetic variants vs. genetic mutations

Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. For Part 1, we’ll discuss the KRAS-variant and KRAS…

Read More ➝
Pills in a bottle to represent medication

Clinical Trial for Patients with the KRAS-variant and HNSCC

Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of HRT in the KRAS-variant patients, and even autoimmunity! Now, we want…

Read More ➝
doctor with tablet pc computer at office

New Partnership Alert: MiraKind & gennev

MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with gennev, a first-of-its-kind telehealth…

Read More ➝
White blood cells of a human, photomicrograph panorama as seen under the microscope, 1000x zoom.

Important Findings From Our Recently Published KRAS-Variant Study

A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal…

Read More ➝
MiraKind Ask me Anything

If I participate in a study will you send me my KRAS-variant results?

We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….

Read More ➝
MiraKind Ask me Anything

Do I need to get tested for KRAS-variant if I’m BRCA positive?

We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…

Read More ➝
MiraKind Ask me Anything

KRAS-Variant and Breast Cancer

Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…

Read More ➝
Scientist using multi-channel pipette for pipetting a 96 well plate with red solution on blue.

New Research: How Inherited DNA -Based Mutations Impact Immunotherapy

The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…

Read More ➝
MiraKind Ask me Anything

HRT and The KRAS-Variant

While there are many factors to consider before taking hormone replacement therapy (HRT), understanding your genetic profile can prove invaluable in your decision-making process. Joanne Weidhaas, MD, PhD, and her colleagues published…

Read More ➝
Test tubes

What You Need to Know About Estrogen and the KRAS-variant

Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Weidhaas and her…

Read More ➝
curve-up2

Disclaimer

Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.

arrow up to top